<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="32106">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02688699</url>
  </required_header>
  <id_info>
    <org_study_id>12243648</org_study_id>
    <nct_id>NCT02688699</nct_id>
  </id_info>
  <brief_title>Additive Hemostatic Efficacy of EndoClot After EMR or ESD in the Gastrointestinal Tract</brief_title>
  <official_title>Italian Multicenter Prospective Randomized Trial to Compare Additive Hemostatic Efficacy of EndoClot System to Prevent Bleeding After Endoscopic Mucosal Resection or Endoscopic Submucosal Dissection of Lesions in the Gastrointestinal Tract</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Turin, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Turin, Italy</source>
  <brief_summary>
    <textblock>
      The investigators want to verify in a randomised trial, the effectiveness of EndoClotTM in
      preventing post-procedural bleeding after EMR (Endoscopic Mucosal Resection) or ESD
      (Endoscopic Submucosal Dissection) for sessile lesions &gt;20 mm in the right colon
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>effectiveness of EndoClotTM in preventing post-procedural bleeding</measure>
    <time_frame>14 days</time_frame>
    <description>The investigators want to verify in a randomised trial, the effectiveness of EndoClotTM in preventing post-procedural bleeding after EMR (Endoscopic Mucosal Resection) or ESD (Endoscopic Submucosal Dissection) for sessile lesions &gt;20 mm in the right colon</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">288</enrollment>
  <condition>Colonic Polyps [C23.300.825.411.235]</condition>
  <arm_group>
    <arm_group_label>EndoClot</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>spraying of Endoclot powder after EMR or ESD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EndoClot</intervention_name>
    <arm_group_label>EndoClot</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 years old

          -  lesions suitable for EMR or ESD

          -  &gt; 20 mm

          -  site in the right colon

        Exclusion Criteria:

          -  Severe cardiovascular pathologies

          -  Liver and Urinary dysfunctions

          -  Hematologic diseases

          -  Pregnancy and breast feeding

          -  impossible follow-up

          -  platelet and coagulation disorders (PLT &lt; 50 x 109/L, INR &gt; 2)

          -  Sensitivity or allergy to the drug
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alberto Arezzo, MD</last_name>
    <phone>+393358378243</phone>
    <email>alberto.arezzo@unito.it</email>
  </overall_contact>
  <verification_date>February 2016</verification_date>
  <lastchanged_date>February 23, 2016</lastchanged_date>
  <firstreceived_date>February 17, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Turin, Italy</investigator_affiliation>
    <investigator_full_name>Alberto Arezzo</investigator_full_name>
    <investigator_title>Associate Professor of Surgery, MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Colonic Polyps</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
